CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: N-(6-acetamidohexyl)acetamide
Accession: CHEBI:125472
browse the term
Definition: An acetamide that has formula C10H20N2O2.
Synonyms: exact_synonym: hexamethylene bisacetamide
related_synonym: Formula=C10H20N2O2; InChI=1S/C10H20N2O2/c1-9(13)11-7-5-3-4-6-8-12-10(2)14/h3-8H2,1-2H3,(H,11,13)(H,12,14); InChIKey=BNQSTAOJRULKNX-UHFFFAOYSA-N; SMILES=CC(=O)NCCCCCCNC(=O)C
alt_id: MESH:C014026
xref: HMDB:HMDB0041901; LINCS:LSM-36966
xref_mesh: MESH:C014026
G
Bax
BCL2 associated X, apoptosis regulator
affects expression
ISO
hexamethylene bisacetamide affects the expression of BAX
CTD
PMID:15543656
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
affects expression
ISO
hexamethylene bisacetamide affects the expression of BCL2
CTD
PMID:15543656
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
multiple interactions
ISO
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA; [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA
CTD
PMID:12130515
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
affects expression
ISO
hexamethylene bisacetamide affects the expression of BCL2L1
CTD
PMID:15543656
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Brd2
bromodomain containing 2
multiple interactions
ISO
hexamethylene bisacetamide inhibits the reaction [BRD2 protein binds to SRM promoter]
CTD
PMID:26941288
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
G
Ccne1
cyclin E1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CCNE1 mRNA
CTD
PMID:17349212
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cd2
Cd2 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD2 mRNA
CTD
PMID:26941288
NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:188,710,900...188,724,026
G
Cd44
CD44 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD44 mRNA
CTD
PMID:17349212
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd52
CD52 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD52 mRNA
CTD
PMID:26941288
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
G
Cd69
Cd69 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD69 mRNA
CTD
PMID:26941288
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Cd74
CD74 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD74 mRNA
CTD
PMID:26941288
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cdc6
cell division cycle 6
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDC6 mRNA
CTD
PMID:26941288
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdc7
cell division cycle 7
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDC7 mRNA
CTD
PMID:26941288
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDK2 mRNA
CTD
PMID:26941288
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
hexamethylene bisacetamide results in increased expression of CDKN1A mRNA; hexamethylene bisacetamide results in increased expression of CDKN1A protein [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of CDKN1A mRNA
CTD
PMID:10597302 PMID:12130515 PMID:17349212
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
hexamethylene bisacetamide results in increased expression of CDKN1B mRNA
CTD
PMID:17349212
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdt1
chromatin licensing and DNA replication factor 1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDT1 mRNA
CTD
PMID:26941288
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Cebpe
CCAAT/enhancer binding protein epsilon
multiple interactions
ISO
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of CEBPE mRNA; [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of CEBPE mRNA
CTD
PMID:12130515
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
G
Chd4
chromodomain helicase DNA binding protein 4
multiple interactions
ISO
[Hemin co-treated with hexamethylene bisacetamide] inhibits the reaction [CHD4 protein binds to OGT protein]; [Hemin co-treated with hexamethylene bisacetamide] inhibits the reaction [thiamet G results in increased O-linked glycosylation of CHD4 protein]; [Hemin co-treated with hexamethylene bisacetamide] results in decreased O-linked glycosylation of CHD4 protein
CTD
PMID:27231347
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Csf1r
colony stimulating factor 1 receptor
increases expression
ISO
hexamethylene bisacetamide results in increased expression of CSF1R mRNA
CTD
PMID:8445950
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Dbf4
DBF4-CDC7 kinase regulatory subunit
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of DBF4 mRNA
CTD
PMID:26941288
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of DUSP6 protein mutant form
CTD
PMID:17569113
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Eif6
eukaryotic translation initiation factor 6
increases expression
ISO
hexamethylene bisacetamide results in increased expression of EIF6 protein
CTD
PMID:17569113
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Hba-a1
hemoglobin alpha, adult chain 1
increases expression
ISO
hexamethylene bisacetamide results in increased expression of HBA-A1 mRNA
CTD
PMID:26941288
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
G
Hexim1
HEXIM P-TEFb complex subunit 1
increases expression
ISO
hexamethylene bisacetamide results in increased expression of HEXIM1 mRNA; hexamethylene bisacetamide results in increased expression of HEXIM1 protein
CTD
PMID:16222702
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
hexamethylene bisacetamide inhibits the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of HMOX1 mRNA]
CTD
PMID:12042074
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hoxa9
homeobox A9
increases expression
ISO
hexamethylene bisacetamide results in increased expression of HOXA9 protein
CTD
PMID:16973558
NCBI chr 4:81,323,235...81,329,344
Ensembl chr 4:81,323,382...81,326,358
G
Hpx
hemopexin
multiple interactions
ISO
hexamethylene bisacetamide inhibits the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of HMOX1 mRNA]; hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT1 mRNA]; hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT2 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT1 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA]
CTD
PMID:12042074
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
multiple interactions
ISO
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of IFIT3 mRNA
CTD
PMID:12130515
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of IGFBP2 mRNA
CTD
PMID:26941288
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Itgam
integrin subunit alpha M
increases expression
ISO
hexamethylene bisacetamide results in increased expression of ITGAM protein
CTD
PMID:10597302
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases phosphorylation increases expression
ISO
hexamethylene bisacetamide results in increased phosphorylation of JUN protein hexamethylene bisacetamide results in increased expression of JUN protein
CTD
PMID:10597302
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Mcm10
minichromosome maintenance 10 replication initiation factor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM10 mRNA
CTD
PMID:26941288
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM2 mRNA
CTD
PMID:26941288
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM3 mRNA
CTD
PMID:26941288
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM4 mRNA
CTD
PMID:26941288
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM5 mRNA
CTD
PMID:26941288
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM6 mRNA
CTD
PMID:26941288
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM7 mRNA
CTD
PMID:26941288
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mpo
myeloperoxidase
multiple interactions
ISO
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in decreased expression of MPO mRNA
CTD
PMID:12130515
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt1
metallothionein 1
multiple interactions
ISO
hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT1 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT1 mRNA]
CTD
PMID:12042074
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
multiple interactions
ISO
hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT2 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA]
CTD
PMID:12042074
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Myb
MYB proto-oncogene, transcription factor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MYB protein
CTD
PMID:10597302
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MYC protein
CTD
PMID:10597302
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Npm1
nucleophosmin 1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of NPM1 protein
CTD
PMID:17569113
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
multiple interactions
ISO
[Hemin co-treated with hexamethylene bisacetamide] inhibits the reaction [CHD4 protein binds to OGT protein]
CTD
PMID:27231347
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Pml
PML nuclear body scaffold
multiple interactions
ISO
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of PML protein mutant form
CTD
PMID:12130515
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pola2
DNA polymerase alpha 2, accessory subunit
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of POLA2 mRNA
CTD
PMID:26941288
NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:203,203,388...203,251,348
G
Pole
DNA polymerase epsilon, catalytic subunit
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of POLE mRNA
CTD
PMID:26941288
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
G
Prim1
DNA primase subunit 1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of PRIM1 mRNA
CTD
PMID:26941288
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prim2
DNA primase subunit 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of PRIM2 mRNA
CTD
PMID:26941288
NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030
G
Rara
retinoic acid receptor, alpha
multiple interactions
ISO
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of RARA protein mutant form
CTD
PMID:12130515
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
hexamethylene bisacetamide results in decreased phosphorylation of RB1 protein
CTD
PMID:10597302
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rpa1
replication protein A1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of RPA1 mRNA
CTD
PMID:26941288
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpa2
replication protein A2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of RPA2 mRNA
CTD
PMID:26941288
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
G
Rpa3
replication protein A3
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of RPA3 mRNA
CTD
PMID:26941288
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
G
RT1-Ba
RT1 class II, locus Ba
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of H2-AA mRNA
CTD
PMID:26941288
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of H2-AB1 mRNA
CTD
PMID:26941288
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of H2-EB1 mRNA
CTD
PMID:26941288
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Sin3b
SIN3 transcription regulator family member B
increases expression
ISO
hexamethylene bisacetamide results in increased expression of SIN3B protein
CTD
PMID:17569113
NCBI chr16:17,123,277...17,159,978
Ensembl chr16:17,123,434...17,159,978
G
Sla
src-like adaptor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of SLA mRNA
CTD
PMID:26941288
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Slamf9
SLAM family member 9
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of SLAMF9 mRNA
CTD
PMID:26941288
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:84,941,982...84,944,748
G
Srm
spermidine synthase
multiple interactions decreases expression
ISO
hexamethylene bisacetamide inhibits the reaction [BRD2 protein binds to SRM promoter] hexamethylene bisacetamide results in decreased expression of SRM mRNA
CTD
PMID:26941288
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srsf1
serine and arginine rich splicing factor 1
increases expression
ISO
hexamethylene bisacetamide results in increased expression of SRSF1 protein
CTD
PMID:17569113
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
ISO
hexamethylene bisacetamide results in increased expression of TUBB4B protein
CTD
PMID:17569113
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all